Furthermore, because the drug still manipulates your metabolic baseline, the risk of rebound weight gain after stopping remains just as real." Several groups should avoid GLP-1s entirely: Those with a personal or family history of medullary thyroid carcinoma or MEN2 Anyone with an active eating disorder Anyone pregnant, breastfeeding, or planning to become pregnant within the next two months (per FDA guidance) Despite how easy it's become to get GLP-1s online via telehealth, a standard prescription model bypasses critical clinical safety guardrails
*Correspondence: Richard Eugene Frye, Arkansas Childrens Hospital Research Institute, Slot 512-41B, 13 Childrens Way, Little Rock, AR 72202, USA e-mail: [email protected] This article was submitted to Child and Neurodevelopmental Psychiatry, a section of the journal Frontiers in Pediatrics
Seeds addresses an important question around the use of GLP-1s for metabolic balancing in patients who do not need to lose weight
The role of oxidative stress in tumorigenesis and progression
[6] This loss of lean tissue is not just a cosmetic concern
,aspect=ignore)
